← All companies
Bio-Rad Laboratories, Inc.
BIO
Market cap$8.09 B
Rank#1080
Filings1,494
The table below shows Bio-Rad Laboratories, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $507.20M | $395.80M | $369.30M | $521.40M | $410.38M | $406.91M |
| Short-term investments | $1.06B | $1.02B | $1.00B | $1.14B | $1.21B | $1.21B |
| Receivables | $426.20M | $464.70M | $469.90M | $424.70M | $461.94M | $445.51M |
| Inventory | $770.50M | $783.20M | $798.80M | $790.10M | $804.28M | $803.69M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.